The particulars: tirzepatide · 25 °C · fourteen days.
I am at the decision point and I would rather think it through than improvise.
I would rather spend money on measurement than on redundancy.
What does a sensible plan look like, and what are the decision points?
Fourteen days at 25 °C is about 56 refrigerated days of equivalent exposure. 25 °C is 20 kelvin above the 5 °C middle of a 2–8 °C refrigerator. The ten-degree rule of thumb — degradation rate roughly doubling per 10 K — makes that about 4 times the refrigerated rate, which is an order-of-magnitude statement and not a shelf life. At 56 equivalent days a test is more likely to reassure you than to tell you something, which is a legitimate reason to run it and a poor reason to expect a finding. Either way, record the fourteen days and the temperature now, while you still know them; an excursion you did not write down is an excursion you cannot interpret later.
The relevant physics is latent heat: a phase-change pack holds temperature only while it is changing phase, and once it has melted it is a warm mass.
Arrhenius behaviour means the degradation rate roughly doubles per ten degrees. A week at thirty degrees is therefore a meaningful exposure for a solution and an immaterial one for a dry solid.
A single-use temperature logger costs a few pounds, records the whole journey and converts an argument into a record. If the history matters, this is the answer.
Solid-state stability of lyophilised peptides at ambient temperature is documented in formulation studies with residual moisture as the dominant variable.
Buy a logger if you actually want to know. Everything else is inference.
Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.
Browse resultsAnswering this needs the transit duration and the ambient temperature, and then the arithmetic is straightforward.
A single phase-change pack in a thin-walled box holds below ten degrees for roughly one to two days at twenty-five degrees ambient, and under a day at thirty-five. On a nine-to-fourteen-day lane the material is at ambient for most of the journey whatever was packed with it.
Concretely, asking a supplier to hold a shipment during a heatwave is reasonable and the better ones agree; the cost is a week and the benefit is a shorter warm exposure for anything in solution.
The domestic leg is the part you control. Refrigerate it promptly.
edited 12 Dec 2024 by tobias_maartens — added the placebo-arm figures
The short version: a spent cold pack on arrival is expected, the solid does not mind, and the pack was never going to last twelve days.
A pack that arrived hard tells you about the last day of transit only, since it will have melted and, if the ambient dropped, partially refrozen.
That is the argument for shipping lyophilised rather than for shipping colder. A dry powder with low residual moisture is stable at ambient for months; the pathways that matter need water.
Single-use temperature loggers are standard practice in supply chains where temperature genuinely matters and are inexpensive at parcel scale.
Solutions are a different question and deserve the worry the solids get.
The honest answer is that the cold pack is doing much less than people think and that shipping lyophilised is what actually protects the material.
Once the parcel arrives, the domestic leg is the controllable part: get it into the refrigerator promptly rather than leaving it in a warm hallway for a day.
The caveat is that a warm transit is survivable for a solid and materially different for a solution.
A liquefied pack is expected. It is not evidence of a problem.
Answer first: for a lyophilised solid the cold chain matters far less than people believe, and for a solution it matters far more than they act as though it does.
Anything shipped in solution is a different risk category, because hydrolysis and deamidation proceed in the aqueous phase and are strongly temperature-dependent.
Phase-change pack hold time is a function of mass, latent heat and insulation, and published figures for small parcels are on the order of one to two days.
Nothing here is medical advice, and research-use compounds are not approved for human use.
Lyophilised tolerates the lane. That is the answer for almost every order.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.